Skip to content

Clinical trials

Phase 3 Small Cell Lung Carcinoma trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 3 Country / region: Turkey (Türkiye) Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20174
20182
20191
20202
20212
20222
20232
20243
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting9
Completed8
Recruiting7
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
AstraZeneca3
Merck Sharp & Dohme LLC3
AbbVie2
Hoffmann-La Roche2
BioNTech SE1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Daiichi Sankyo1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma25
Lung Neoplasms3
Carcinoma1
Neoplasm Metastasis1
Neoplasms1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.